Cargando…

Experience in recruiting youths in HIV vaccine trials in Tanzania: the TaMoVac 01 study

Detalles Bibliográficos
Autores principales:	Massawa, T, Swalehe, A, Niima, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441368/ http://dx.doi.org/10.1186/1742-4690-9-S2-P125

Ejemplares similares

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania
por: Mann, PJ, et al.
Publicado: (2012)

Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam
por: Ngatoluwa, M, et al.
Publicado: (2012)

The recruitment and retention of high risk youth in HIV/AIDS clinical trials in post-conflict Liberia
por: Woods, Daisajou V, et al.
Publicado: (2009)

P17-01. HIV-specific immune responses induced by a single dose of HIV DNA vaccine in Rhesus macaques
por: Arrode-Brusés, G, et al.
Publicado: (2009)

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India
por: Kochhar, S, et al.
Publicado: (2009)

P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy
por: Skinner, JA, et al.
Publicado: (2009)

PA01.14. Study of Herbal combination in HIV infection
por: Tumbare, Sanjay, et al.
Publicado: (2012)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

P19-01. Pre-clinical immunogenicity of mosaic Asian AE/B HIV-1 DNA vaccine in mice
por: Sirivichayakul, S, et al.
Publicado: (2009)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

P01-18 Physical activity for children and youth with Physical disabilities - a case study on implementation in the municipality-setting
por: Præst, Charlotte, et al.
Publicado: (2022)

P20-01. HIV-1 genetic diversity among HIV drug naive populations of Nairobi, Kenya
por: Nyamache, AK, et al.
Publicado: (2009)

P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens
por: Reddy, S Mohana Rama, et al.
Publicado: (2009)

Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
por: Mata-Fink, J, et al.
Publicado: (2012)

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy
por: Craigo, JK, et al.
Publicado: (2009)

PA01.01. Effect of rakthamoksha in sandhigata vata with special reference to osteoarthritis
por: Poulose, Pouse
Publicado: (2013)

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
por: Salmon-Céron, D, et al.
Publicado: (2009)

PA01.01. 22. Gradation method - A new approach for prakruti assesment
por: Bhutada, Sarita S
Publicado: (2012)

Transition to adult clinics in youth living with HIV since birth
por: Fernet, Mylène, et al.
Publicado: (2010)

Antiretroviral strategies for the treatment of pregnant HIV+ women and prevention of perinatal HIV transmission in Dodoma, Tanzania: AMANI Study
por: Liuzzi, G, et al.
Publicado: (2010)

P06-01. Developing a sponsor-initiated clinical guidance for AIDS vaccine research
por: Priddy, F, et al.
Publicado: (2009)

P01-05. Rapid perforin upregulation dominates the HIV-specific CD8 T cell response during acute HIV-infection
por: Makedonas, G, et al.
Publicado: (2009)

P01-04. Investigation of the sensitivity of acute-phase HIV-1 isolates to type I interferons
por: Dibben, O, et al.
Publicado: (2009)

Methodological lacunae in recruitment of HIV positive persons in randomized controlled trials
por: Sharma, Arun K, et al.
Publicado: (2014)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
por: Lynch, RM, et al.
Publicado: (2012)

P15-30 LB. An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials
por: Johnson, D, et al.
Publicado: (2009)

PA01.51.Enriching the core
por: Thakkar, Jayesh
Publicado: (2012)

Lymphoproliferative responses to HIV-1 Gag p24 antigen and mitogens in HIV-1 subtype CRF01_AE infected Thai patients and HIV-1 seronegative donors
por: Chuenchitra, Thippawan, et al.
Publicado: (2006)

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies
por: Joyce, M, et al.
Publicado: (2012)

P01.01. Neural responses to the mechanical characteristics of a spinal manipulation: effect of varying segmental contact site
por: Pickar, J, et al.
Publicado: (2012)

PA01.01. A clinical study on the effect of paneeya kshara in the management of asmari w.s.r. to urinary calculi
por: Chakradhar, K V
Publicado: (2012)

The evolution of HIV-1 subtypes and disease progression among adults on anti-retroviral drugs in Northern Tanzania
por: Shao, E, et al.
Publicado: (2012)

Inflammatory status affects the antitumor activity of poly-epitope-peptide vaccination against the thymidylate synthase in metastatic colo-rectal cancer patients enrolled in TSPP/VAC-1 Phase Ib trial
por: Correale, Pierpaolo, et al.
Publicado: (2015)

PA01.78. Ayurvedic diet in pregnancy
por: Koli, Deepali Babasaheb
Publicado: (2012)

PA01.03. Rural health and snakebite
por: Dutta, Arun Kumar, et al.
Publicado: (2012)

PA01.13. Hemiplegia - An ayurvedic perspective
por: Hariharan, Subramanian, et al.
Publicado: (2012)

P01-01 Assessment of local governments’ involvement in sport and physical activity policy promotion – LoGoPAS project
por: Sandu, Petru, et al.
Publicado: (2022)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

P08-01. Heme oxygenase-1 promoter polymorphisms correlate with favorable virologic and immunological parameters in HIV-1 infection
por: Seu, L, et al.
Publicado: (2009)

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2(nd) line antiretroviral regimen
por: Nouhin, Janin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lnf14vhstufg91tbauq7pnfgfn